articles
- Novel exomic rare variants associated with venous thrombosis 2020
- Elevated fetal haemoglobin is a predictor of better outcome inMDS/AML patients receiving 5-aza-2-deoxycytidine (Decitabine). 176:609-617. 2017
- Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma. 172:889-901. 2016
- Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity. 164:233-244. 2014
- Warfarin untargeted metabolomics study identifies novel procoagulant ethanolamide plasma lipids. 165:409-412. 2014
- Indications for a protective function of beta(2)-glycoprotein I in thrombotic thrombocytopenic purpura. 159:94-103. 2012
- Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells. 157:270-274. 2012
- Ernest Beutler: His life and contribution to medical science. 152:543-550. 2011
- Function of the activated protein c (apc) autolysis loop in activated fviii inactivation. 153:644-654. 2011
- Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network. 153:741-752. 2011
- Pathogenesis of chronic immune thrombocytopenia: Increased platelet destruction and/or decreased platelet production. 146:585-596. 2009
- Suppression of the hepcidin-encoding gene hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/tmprss6. 147:571-581. 2009
- HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. 141:179-187. 2008
- Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9. 139:138-147. 2007
- Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates. 132:197-203. 2006
- Hemojuvelin (hjv) mutations in persons of european, african-american and asian ancestry with adult onset haemochromatosis. 127:224-229. 2004
- Haematological effects of the c282yhfe mutation in homozygous and heterozygous states among subjects of northern and southern european ancestry. 120:887-893. 2003
- Screening strategies in C282Y-linked haemochromatosis. 120:1089-1090. 2003
- Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II. 117:676-684. 2002
- Many α(IIb)β(3) autoepitopes in chronic immune thrombocytopenic purpura are localized to α(IIb) between amino acids L1 and Q459. 118:1132-1136. 2002
- Haemolytic onset of Wilson disease in a patient with homozygous truncation of ATP7B at Arg1319. 114:230-232. 2001
- Human transferrin g277s mutation: A risk factor for iron deficiency anaemia. 115:329-333. 2001
- Reduced activity of tafi (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia. 108:518-523. 2000
- Leukaemia inhibitory factor enhances tissue factor expression in human monocyte-derived macrophages: A gp130-mediated mechanism. 107:747-755. 1999
- Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. 107:275-281. 1999
- A non-thrombocytopenic bleeding disorder due to an igg4-kappa anti-gpiib/iiia autoantibody. 95:747-749. 1996
- Reactivity of autoantibodies from chronic itp patients with recombinant glycoprotein iiia peptides. 91:178-184. 1995
- Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumor-cells. 83:545-553. 1993
- Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. 79:286-290. 1991
- Autoantibodies to platelet glycoproteins in patients with disease-related immune thrombocytopenia. 73:365-368. 1989
- Menstrual cyclic thrombocytopenia. 71:519-524. 1989
- Autoantibodies against platelet gpiib/iiia in chronic itp react with different epitopes. 67:345-348. 1987
- Alteration of red cell membrane organization in sickle cell anaemia. 63:761-773. 1986
- Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura. 63:293-300. 1986
- von Willebrand factor, now cloned. 64:15-20. 1986
- Heterogeneity of hereditary and acquired factor-x deficiencies by combined immunochemical and functional analyses. 59:235-248. 1985
- Platelet-associated complement in chronic itp. 60:723-733. 1985
- Hybridoma antibodies to human von Willebrand factor. I. Characterization of seven clones. 57:597-608. 1984
- Hybridoma antibodies to human von willebrand factor .2. Relative role of intramolecular loci in mediation of platelet-adhesion to the subendothelium. 57:609-620. 1984
- Platelet antigens in chronic idiopathic thrombocytopenic purpura. 56:529-534. 1984
- Evaluation of platelet surface-antigens - localization of the plal alloantigen. 51:297-304. 1982
- Fixation of c-3 to platelets in vitro by anti-platelet antibody from patients with immune thrombocytopenic purpura. 47:251-256. 1981
- Adrenaline binding-site on human-platelets. 41:597-604. 1979
- Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds. 40:643-655. 1978
- Spectrum of von Willebrand's Disease: a study of 100 cases. 35:101-112. 1977
- Different antiplatelet antibody specificities in immune thrombocytopenic purpura. 34:147-151. 1976
- Immunoradiometric assay of factor VIII related antigen, with observations in 32 patients with von Willebrand's disease. 33:221-232. 1976
- Nervous regulation of factor-VIII levels in man. 20:195-207. 1971